Sign up
Quantellect · Congress · Trade Detail
SAGESAGE THERAPEUTICS INCORPORATED (SAGE)
RepublicanHouse

James B. Renacci bought SAGE THERAPEUTICS INCORPORATED (SAGE) (SAGE)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 7 trades in SAGE THERAPEUTICS INCORPORATED (SAGE) (SAGE) since 2015, 5 purchases and 2 sales, worth an estimated $130K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: James B. Renacci bought $1,000 - $15,000 of SAGE THERAPEUTICS INCORPORATED (SAGE) (SAGE) on March 25, 2015. Since that trade, SAGE is down -30.23% against the S&P 500 up +326.20%, an outperformance of -356.43%.

Across these filings, James B. Renacci has been a net buyer of SAGE (a buy-to-sell ratio of 2.50). The most recent disclosed SAGE transaction shown was dated November 3, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

SAGE trades
7
Disclosed Vol
$130K
Buys
5
71%
Sells
2
29%
Buy / Sell
2.50
ratio
First → Last
2015–2017

James B. Renacci's SAGE trades vs the price

SAGE is down -30.23% since James B. Renacci bought on March 25, 2015, versus +326.20% for the S&P 500.

Performance since this trade

Price change since trade
-30.23%
S&P 500 change since trade
+326.20%
Outperformance vs S&P 500
-356.43%

All James B. Renacci SAGE trades

TradedTypeSizeReturnEst. profit
November 3, 2017SELL$15,001 - $50,000N/A
September 12, 2017BUY$1,000 - $15,000N/A
August 3, 2016BUY$1,000 - $15,000N/A
January 11, 2016BUY$15,001 - $50,000N/A
December 9, 2015SELL$15,001 - $50,000N/A
June 18, 2015BUY$1,001 - $15,000N/A
March 25, 2015BUY$1,000 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & SAGE trading FAQ

Is it legal for James B. Renacci to trade SAGE THERAPEUTICS INCORPORATED (SAGE) (SAGE) stock?

Yes. Members of Congress are allowed to trade individual stocks, including SAGE THERAPEUTICS INCORPORATED (SAGE) (SAGE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci buy SAGE?

James B. Renacci disclosed a purchase of $1,000 - $15,000 of SAGE THERAPEUTICS INCORPORATED (SAGE) (SAGE) on March 25, 2015, according to public STOCK Act filings.

How has SAGE performed since James B. Renacci's trade?

Since James B. Renacci bought SAGE on March 25, 2015, the stock is down -30.23%, versus +326.20% for the S&P 500 over the same period, an outperformance of -356.43%.

How many times has James B. Renacci traded SAGE?

James B. Renacci has disclosed 7 SAGE trades since 2015 (5 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional SAGE trades?

Quantellect tracks every disclosed congressional trade in SAGE THERAPEUTICS INCORPORATED (SAGE) (SAGE) on the SAGE THERAPEUTICS INCORPORATED (SAGE) congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's SAGE tradesAll congressional filings for SAGE THERAPEUTICS INCORPORATED (SAGE)James B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.